KURE holds all types of publicly-issued shares (including A-shares, B-shares, H-shares, N-shares, P-chips, and Red chips) of large- and mid-cap Chinese companies in the healthcare sector. Stocks must meet minimum trading and liquidity requirements and be classified in the healthcare sector under MSCIs GICS standard. Holdings are market cap-weighted with an adjustment based on the proportion of shares available to foreign investorsexcept for A-shares, which are treated as 100% available. Weights are also modified using a 10/40 capping methodology. Overall, KURE provides exposure to a relatively small slice of the Chinese economy. The index is rebalanced quarterly.